Skip to main content

Infusion Pumps Market Size & Share | To Reach USD 16.09 billion, While Exhibiting an stunning CAGR of 7.1%

Infusion Pumps Market to Exhibit a CAGR of 7.1% and reach USD 16.09 Billion by 2026; Adoption of Advanced Treatment Techniques to Propel Market, states Fortune Business Insights™

Pune, India, Feb. 10, 2022 (GLOBE NEWSWIRE) — The global infusion pumps market size worth USD 16.09 billion by 2026, exhibiting a CAGR of 7.1% during the forecast period. As per the published report by Fortune Business Insights, titled “Market Size, Share & Industry Analysis, By Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management, and Others), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others), and Regional Forecast, 2019-2026” the market size stood at USD 9.28 billion in 2018.

Key Development:

April 2017: Acquisition of BD for Caesarea Medical Electronics, the infusion pumps manufacturing company. The strategic acquisition will help the companies to cater to the advanced technological development of innovative infusion pumps.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/infusion-pump-market-102554


Market Growth Factors:

Growing Cases of Cancer and Diabetes to Aid Market Expansion

  • Increase in geriatric population and rise in prevalence of chronic diseases. In addition, surge in adoption of portable infusion pumps to reduce hospital expenditure is expected to supplement the growth. Conversely, technological advancements in infusion pumps are expected to create lucrative opportunities for key market players during the forecast period.
  • The increasing prevalence of chronic diseases will spur demand for infusion pumps in the forthcoming years. Moreover, the growing advancements in drug delivery systems will boost the infusion pumps market trends during the forecast period.
  • The increasing adoption of advanced treatment techniques will have a positive impact on the Infusion Pumps Market growth in the foreseeable future. The increasing incidence of cancer among patients will spur opportunities for the market during the forecast period.
  • According to the World Health Organization (WHO), in 2018, cancer was estimated to be the second most prominent cause of death globally and is responsible for about 9.6 million deaths. Cancer patients require chemotherapy which is to be delivered to the patients in a continuous manner which can be achieved by using the infusion pumps.


To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/infusion-pump-market-102554


Market Segments Analysis:

On the basis of end user, the hospitals & clinics segment led the market in 2020, and is anticipated to maintain its lead during the forecast period.

On the basis of type, the volumetric infusion pumps segment was the major revenue contributor in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in adoption of technologically advanced volumetric infusion pumps that exhibit the capabilities such as electronic health record (EHR) integration, built-in safety systems, as well as drug library, which is a list of drugs stored in the smart pump’s memory, serving as a key tool to prevent medication errors.


Quick Buy this Report: https://www.fortunebusinessinsights.com/checkout-page/102554


Regional Analysis:

Favorable Reimbursement Policies to Boost Infusion Pumps Market Growth in North America

The market in North America stood at USD 3.41 billion in 2018. The growth in region is attributed to higher diagnosis and treatment rates for diabetes coupled with high adoption of ambulatory infusion pumps. Moreover, favorable reimbursement policies will aid growth in the region.

Europe is predicted to witness steady growth during the forecast period owing to the prevalence of chronic diseases in the region. Asia Pacific is predicted to grow significantly during the forecast period owing to the growing healthcare infrastructure, growing GDP, increasing per capita disposable income.


Key Companies in the Infusion Pumps Market:

•              Medtronic

•              BD

•              Baxter

•              Insulet Corporation

•              icumedical

•              B. Braun Melsungen AG

•              Smiths Medical (Smiths Group plc.)

•              Fresenius Kabi AG

•              Terumo Corporation


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/infusion-pump-market-102554


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.